Maino Kimberly L, Norwood Christopher, Stashower Mitchell E
Division of Clinical Research, National Naval Medical Center, 8901 Wisconsin Ave, Bethesda, MD 20899, USA.
Cutis. 2003 Sep;72(3):234-6.
Capecitabine is an antineoplastic agent that is currently the only effective treatment for patients with advanced or metastatic breast cancer in whom anthracycline or taxoid treatment has failed. Dermatologic side effects have included hand-foot syndrome and one case of onycholysis. We report a case of onycholysis with appearance of a "sunset" induced by capecitabine.
卡培他滨是一种抗肿瘤药物,目前是蒽环类或紫杉类治疗失败的晚期或转移性乳腺癌患者的唯一有效治疗方法。皮肤副作用包括手足综合征和1例甲床分离症。我们报告1例由卡培他滨引起的出现“日落征”的甲床分离症病例。